Delivery Order SPE2DB22D3010-SPE2DB25FP3HB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,906.47 by the Defense Logistics Agency for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. The ultimate completion date is August 15, 2025, with performance to be conducted at the contractor's Conshohocken facility. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,287.74 firm fixed-price delivery order from the Defense Logistics Agency for Zepbound 5 mg/0.5 ml pen injectors. This delivery order, awarded without set-aside on September 2, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,040.82 by the Defense Logistics Agency (DLA) for Zepbound 5 mg/0.5 ml pens. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,287.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,478.28 by the Defense Logistics Agency on August 14, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 15, 2025. This award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $11,592.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3HBDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,994.81 by the Defense Logistics Agency on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery location is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems. The company's broad portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, and other therapeutic products. The DLA Troop Support Medical IDC represents a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide through flexible delivery orders, while the Defense Logistics Agency simultaneously plans to establish new Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards across different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/26/25 |